Your browser doesn't support javascript.
loading
Efficacy and safety of brexpiprazole for the treatment of acute schizophrenia in Japan: A 6-week, randomized, double-blind, placebo-controlled study.
Ishigooka, Jun; Iwashita, Shuichi; Tadori, Yoshihiro.
Affiliation
  • Ishigooka J; Institute of CNS Pharmacology, Tokyo, Japan.
  • Iwashita S; Headquarters of Clinical Development, Otsuka Pharmaceutical Co., Ltd., Osaka, Japan.
  • Tadori Y; Department of Medical Affairs, Otsuka Pharmaceutical Co., Ltd., Tokyo, Japan.
Psychiatry Clin Neurosci ; 72(9): 692-700, 2018 Sep.
Article in En | MEDLINE | ID: mdl-29774628
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Schizophrenia / Thiophenes / Quinolones Type of study: Clinical_trials Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Psychiatry Clin Neurosci Journal subject: NEUROLOGIA / PSIQUIATRIA Year: 2018 Document type: Article Affiliation country: Japón Country of publication: Australia
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Schizophrenia / Thiophenes / Quinolones Type of study: Clinical_trials Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Psychiatry Clin Neurosci Journal subject: NEUROLOGIA / PSIQUIATRIA Year: 2018 Document type: Article Affiliation country: Japón Country of publication: Australia